全文获取类型
收费全文 | 29033篇 |
免费 | 2698篇 |
国内免费 | 722篇 |
专业分类
耳鼻咽喉 | 662篇 |
儿科学 | 585篇 |
妇产科学 | 257篇 |
基础医学 | 2207篇 |
口腔科学 | 461篇 |
临床医学 | 4214篇 |
内科学 | 3527篇 |
皮肤病学 | 366篇 |
神经病学 | 2787篇 |
特种医学 | 477篇 |
外国民族医学 | 3篇 |
外科学 | 1509篇 |
综合类 | 4704篇 |
现状与发展 | 3篇 |
一般理论 | 1篇 |
预防医学 | 3897篇 |
眼科学 | 383篇 |
药学 | 2457篇 |
38篇 | |
中国医学 | 3210篇 |
肿瘤学 | 705篇 |
出版年
2024年 | 99篇 |
2023年 | 716篇 |
2022年 | 1021篇 |
2021年 | 1582篇 |
2020年 | 1533篇 |
2019年 | 1306篇 |
2018年 | 1371篇 |
2017年 | 1227篇 |
2016年 | 1286篇 |
2015年 | 1092篇 |
2014年 | 2282篇 |
2013年 | 2360篇 |
2012年 | 1995篇 |
2011年 | 2000篇 |
2010年 | 1525篇 |
2009年 | 1302篇 |
2008年 | 1258篇 |
2007年 | 1257篇 |
2006年 | 1014篇 |
2005年 | 868篇 |
2004年 | 732篇 |
2003年 | 735篇 |
2002年 | 449篇 |
2001年 | 462篇 |
2000年 | 351篇 |
1999年 | 336篇 |
1998年 | 236篇 |
1997年 | 222篇 |
1996年 | 196篇 |
1995年 | 188篇 |
1994年 | 168篇 |
1993年 | 121篇 |
1992年 | 107篇 |
1991年 | 91篇 |
1990年 | 95篇 |
1989年 | 76篇 |
1988年 | 65篇 |
1987年 | 63篇 |
1986年 | 41篇 |
1985年 | 97篇 |
1984年 | 87篇 |
1983年 | 75篇 |
1982年 | 73篇 |
1981年 | 51篇 |
1980年 | 66篇 |
1979年 | 27篇 |
1978年 | 42篇 |
1977年 | 21篇 |
1976年 | 19篇 |
1974年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 750 毫秒
61.
M. Mizuguchi H. Yamanouchi T. Ichiyama M. Shiomi 《Acta neurologica Scandinavica》2007,115(S186):45-56
Acute encephalopathy is the most serious complication of pediatric viral infections, such as influenza and exanthem subitum. It occurs worldwide, but is most prevalent in East Asia, and every year several hundreds of Japanese children are affected by influenza-associated encephalopathy. Mortality has recently declined, but is still high. Many survivors are left with motor and intellectual disabilities, and some with epilepsy. This article reviews various syndromes of acute encephalopathy by classifying them into three major categories. The first group caused by metabolic derangement consists of various inherited metabolic disorders and the classical Reye syndrome. Salicylate is a risk factor of the latter condition. The second group, characterized by a systemic cytokine storm and vasogenic brain edema, includes Reye-like syndrome, hemorrhagic shock and encephalopathy syndrome, and acute necrotizing encephalopathy. Non-steroidal anti-inflammatory drugs, such as diclofenac sodium and mephenamic acid, may aggravate these syndromes. Severe cases are complicated by multiple organ failure and disseminated intravascular coagulation. Mortality is high, although methylprednisolone pulse therapy may be beneficial in some cases. The third group, characterized by localized edema of the cerebral cortex, has recently been termed acute encephalopathy with febrile convulsive status epilepticus, and includes hemiconvulsion-hemiplegia syndrome and acute infantile encephalopathy predominantly affecting the frontal lobes. Theophylline is a risk factor of these syndromes. The pathogenesis is yet to be clarified, but an increasing body of evidence points to excitotoxicity and delayed neuronal death. 相似文献
62.
益气复智颗粒对多发脑梗死性痴呆模型大鼠脑组织细胞凋亡的影响 总被引:1,自引:0,他引:1
目的 观察益气复智颗粒对多发脑梗死性痴呆模型大鼠脑皮质形态学、细胞凋亡的影响。方法 采用颈内动脉注射血栓的方法,复制多发梗死性痴呆大鼠模型,观察益气复智颗粒12.42g/kg分别于手术前、手术前后、手术后灌胃对实验动物脑皮质形态学、细胞凋亡的影响。结果 益气复智颗粒能使脑缺血后脑内神经细胞凋亡数目下降。结论 益气复智颗粒具有较好的保护脑神经元,阻断脑缺血致神经细胞死亡病理过程的作用。 相似文献
63.
17β-雌二醇对子宫内膜异位症患者在位子宫内膜间质细胞β-catenin mRNA和蛋白表达的影响 总被引:2,自引:0,他引:2
目的研究17β-雌二醇(17β-E2)对子宫内膜异位症(内异症)患者在位子宫内膜间质细胞β-catenin mRNA和蛋白表达的影响,探讨Wnt/β-catenin信号通路在介导雌激素促进内异症发生发展的作用。方法体外分离培养内异症患者在位子宫内膜间质细胞。用不同浓度17β-E2处理子宫内膜间质细胞48 h;此后选用10-10mol/L 17β-E2处理子宫内膜间质细胞12、24和48 h,逆转录聚合酶链反应(RT-PCR)和免疫印迹法(Western blotting)检测17β-E2处理前后子宫内膜间质细胞β-catenin mRNA和蛋白的表达水平。同法分析雌激素受体拮抗剂ICI182,780(10-6mol/L)对17β-E2促进β-catenin mRNA和蛋白表达的影响。免疫组织化学染色观察17β-E2作用后β-catenin在子宫内膜间质细胞中的定位。结果17β-E2能明显促进内异症患者在位子宫内膜间质细胞β-catenin mRNA和蛋白的表达,并呈剂量和时间依赖性,于10-10mol/L作用48 h最明显。雌激素受体拮抗剂ICI182,780能明显抑制17β-E2对子宫内膜间质细胞β-catenin mRNA和蛋白的表达。免疫组织化学染色发现17β-E2能促进β-catenin在子宫内膜间质细胞核内的表达。结论雌激素可能通过激活Wnt/β-catenin信号通路促进内异症在位子宫内膜的异位种植。 相似文献
64.
刘素琴 《中华现代儿科学杂志》2005,2(12):1073-1074
目的 探讨更昔洛韦对婴幼儿手足口病(HFMD)的临床疗效。方法 将65例婴幼儿HFMD患儿随机分为治疗组和对照组,治疗组加用更昔洛韦,观察临床有效率及不良反应率,并对结果进行统计学分析。结果 临床有效率治疗组为90.91地,对照组56.25%,引起白细胞下降,血小板下降治疗组为33.33%、27.27%,对照组为9.38%、3.13%,差异均有显著性。结论 治疗组疗效优于对照组,但须随访对白细胞和血小板的影响。 相似文献
65.
66.
目的:考核HFRS地鼠肾细胞Ⅱ型灭活疫苗的安全性、免疫法及其流行病学效果。方法:采用间接免疫荧光抗体试验(IFA)、微量细胞变性中和试验(MCPENT),检测接种者血中荧光抗体及中和抗体水平;调查接种组与对照组发病情况。结果:以怀宁、广德两县18个村为疫苗观察现场,接种组7499人,对照组7261人,中强反应率为224%(5/223)。3针全程免疫后中和抗体阳转率为63.33%(19/30),荧光抗体阳转率为38.58%(27/70);接种后1年内接种组无发病,对照组发病3例。结论:该疫苗的安全性较好;有一定水平的免疫应答,但防病效果应进一步观察确证。 相似文献
67.
肺系疾病从脾胃论治的探讨 总被引:5,自引:1,他引:4
史锁芳 《南京中医药大学学报》1998,14(6):323-325
本文论述与肺与脾胃在生理,病理诸方面的密切关系;提出了肺系疾病从脾胃治疗的必要性和重要性;讨论了肺病从脾胃论治之常用7法:即健脾化痰法,芳香醒脾法,健脾利水法,通腑降气法,健脾补肺法,养胃益肺法,补益脾肾法等,对肺系疾病的临床治疗有一定的启发作用和应用价值。 相似文献
68.
C. J. Bowden W. D. Figg N. A. Dawson O. Sartor R. J. Bitton M. S. Weinberger Donna Headlee Eddie Reed C. E. Myers M. R. Cooper 《Cancer chemotherapy and pharmacology》1996,39(1-2):1-8
Introduction: Suramin is a synthetic polysulfonated naphthylurea which has been used for the treatment of African trypanosomiasis and onchocerciasis,
but since the mid-1980s has received attention as a possible antiretroviral and antineoplastic agent. Objective: This clinical trial of suramin was undertaken as a phase I/II study in patients with hormone-refractory prostate cancer,
with the hypothesis that the intensity of therapy with suramin could be increased significantly if measures were undertaken
to maintain the plasma concentrations of the drug under 300 μg/ml. Methods: We report the clinical results of this trial, wherein patients were treated at three different targeted plasma suramin concentrations
(275, 215 and 175 μg/ml) for varying periods of time (2, 4 or 8 weeks), with delivery of the drug by continuous intravenous
infusion. Results: The major toxicity observed in this trial was neurologic, consisting of a motor and sensory peripheral neuropathy that resulted
in both paresis and paralysis of the limbs. Nearly all of this severe (CTEP grade III, IV) neurologic toxicity was observed
in the patients treated at a plasma suramin concentration of 275 μg/ml for 4 or more weeks. A single patient treated at 215 μg/ml
for 8 weeks developed moderate (CTEP grade III) proximal lower extremity weakness, and no patient treated at 175 μg/ml developed
this toxicity. The second most common toxicity observed was infection of the central venous catheter. The overall response
rate for all of the evaluable patients was 17% (13 of 75 patients). In addition, prostate-specific antigen (PSA)-defined responses
were observed in six patients receiving therapy at 175 μg/ml, but these responses were confounded by cessation of therapy
with flutamide during suramin treatment. Conclusions: In summary, although plasma suramin concentrations were maintained below 300 μg/ml, neurologic toxicity nonetheless occurred
with high frequency in patients treated at 275 μg/ml for 4 or more weeks. Therapy at 215 and 175 μg/ml was in general well
tolerated, but central venous catheter-related infection, as well as the inconvenience and expense of continuous infusional
therapy, make this method of drug delivery impractical. Only moderate antitumor activity was observed during this trial, but
it is possible that both continuation of flutamide and flutamide withdrawal during suramin therapy confounded the assessment
of suramin’s activity in hormone-refractory prostate cancer.
Received: 9 June 1995/Accepted: 18 March 1996 相似文献
69.
目的探讨镍钛记忆合金带膜内支架在治疗食管癌术后胸内吻合口瘘中的应用价值。方法在X线电视透视下对22例食管癌术后胸内吻合口瘘患者进行镍钛记忆合金带膜内支架植入治疗。结果19例一次植入成功,成功率86%,恢复正常饮食;不完全封堵瘘口3例(14%);16例术后出现轻度的胸骨后疼痛不适或胃液反流的症状;1例出现上消化道大出血。22例病人均治愈出院,治愈率100%。结论镍钛记忆合金带膜内支架植入治疗食管癌术后胸内吻合口瘘成功率高,治愈率高,操作简单,安全,见效快,并发症少,有效解除患者痛苦,宜在临床上推广使用。 相似文献
70.
静脉输液加药后的微粒变化 总被引:7,自引:1,他引:6
本文对我院急诊病人常用的供静脉给药的22种药物、42组配伍情况,制成静脉加药输液,在超净工作台条件下,用KF—4型微粒计数器,测定了168次微粒数,结果显示输液加药后微粒虽有增加,但均在药典规定范围内。输液中加1种、2种、3种药物后所产生的微粒数分别为x_1=5.52(n_1=16);x_2=8.17(n_2=18)、x_3=10.25(n_3=8),经统计处理,三组间无显著差异(P<0.05)。本文对产生微粒的药物、注射器、操作环境等因素进行了分析。 相似文献